First Phosphonic-Type Inhibitors and Activity-Based Probes Specific to the O'nyong-nyong Virus Capsid ProteaseCHEMMEDCHEMIF3.42025-04-010PRE
SARS-CoV-2 M pro oligomerization as a potential target for therapy(vol 267, 131392, 2024)INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULESIF8.52024-09-010PRE
SARS-CoV-2 Mpro oligomerization as a potential target for therapyINTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULESIF8.52024-05-012OAAI
Despite the odds: formation of the SARS-CoV-2 methylation complexNUCLEIC ACIDS RESEARCHIF13.12024-03-180OAAI
Autoinhibition of suicidal capsid protease from O'nyong'nyong virusINTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULESIF8.52024-03-010PRE
Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronavirusesCELL CHEMICAL BIOLOGYIF7.22022-05-0142OAAI